Ambalum, Mike M.

HRN: 22-59-27  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2023
CEFUROXIME 1.5GM (VIAL)
02/15/2023
02/22/2023
IV
3G
OD
For Empiric Therapy
Waiting Final Action 
02/15/2023
CEFTRIAXONE 1G (VIAL)
02/15/2023
02/22/2023
IV
2.5 G
Q24
AGE W Severe; T/C UTI
Waiting Final Action 
02/16/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
02/16/2023
02/18/2023
ORAL
10ml
OD
Ascariasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: